Neural crest-derived mesenchymal progenitor cells enhance cranial allograft integration

Area of Science:

• Regenerative Medicine
• Craniofacial Surgery
• Stem Cell Biology

Background:

• Cranial bone defects pose significant challenges, often requiring nonviable allografts.
• Existing methods using bone marrow-derived mesenchymal stromal cells (BM-MSCs) to revitalize allografts show limited success.
• Neural crest cells are crucial for craniofacial development, suggesting their progenitor cells could be beneficial.

Purpose of the Study:

• To investigate the efficacy of induced neural crest cell-mesenchymal progenitor cells (iNCC-MPCs) in enhancing cranial allograft integration.
• To compare the performance of iNCC-MPCs with conventional BM-MSCs for cranial bone repair in a mouse model.

Main Methods:

• Human induced pluripotent stem cells were differentiated into iNCC-MPCs.
• iNCC-MPCs and BM-MSCs were characterized and labeled with luciferase for in vivo tracking.
• Calvarial defects in NOD/SCID mice were treated with cell-coated allografts (iNCC-MPCs or BM-MSCs) or cell-free allografts.
• Bioluminescence imaging, microcomputed tomography, histology, immunofluorescence, and biomechanical testing were employed for evaluation.

Main Results:

• In vitro characterization showed no significant differences between iNCC-MPCs and BM-MSCs in MSC markers or differentiation capacity.
• In vivo bioluminescence imaging confirmed the survival of both cell types for at least 8 weeks.
• Microcomputed tomography revealed enhanced structural parameters with iNCC-MPCs and increased bone volume with BM-MSCs compared to controls at 8 weeks.
• Histological analysis demonstrated superior allograft integration with iNCC-MPCs compared to BM-MSCs and controls.
• Biomechanical testing indicated improved properties in iNCC-MPC-coated allografts.

Conclusions:

• Coating cranial allografts with iNCC-MPCs significantly enhances implant-to-bone integration and biomechanical strength.
• iNCC-MPCs demonstrate superior performance compared to BM-MSCs in promoting cranial allograft integration.
• Induced neural crest cell-mesenchymal progenitor cells represent a promising cell source for regenerative strategies in cranial bone repair.